Parallel Purification of High-Quality Therapeutic Targets
Learn about our semi-automated chromatography platform for parallel purification of high-quality therapeutic targets. At PEGS Europe 2023, WuXi AppTec scientists described an automated workflow integrated with a serial size exclusion platform, resulting in a complete purification scheme for the rapid purification of high-quality proteins expressed in E. coli, insect cells, and mammalian cells. This approach enables a single user to perform 12 purifications in just 2 working days!
PEGS Europe 2023 Poster B034_A Semi-Automated Chromatography Platform for Parallel Purification of High Quality Therapeutic Targets
Related Content
The EML4-ALK fusion gene occurs in approximately 5% of non-small-cell lung cancers (NSCLCs), making this oncogene an important drug target. ...
VIEW RESOURCEWuXi AppTec offers Jurkat reporter cell lines for immunotherapy drug screening. Our platform includes CD8+, TCR knockout and CD16-expressing Jurkat-NFAT-Luc...
VIEW RESOURCE